Date: 21.7.2025
Bioengineered organs are no longer just structural substitutes. A review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) platforms – living constructs integrated with electronics that can monitor, modulate, and even autonomously control their own functions.
Traditional bioengineered organs have been limited in their ability to replicate the complex and dynamic nature of human organs. BHET platforms aim to change that by turning passive constructs into intelligent systems.
These systems have already shown promise in diverse applications: brain organoids learning through neural feedback, cardiac tissues synchronizing contractions with external pacing, and engineered ? cells releasing insulin in response to electrical signals.
Such platforms blur the line between biology and machine, turning tissues into responsive and programmable devices.
The review also explores future directions, including AI-driven control systems, conductive hydrogel electrodes, and scalable 3D bioprinting techniques that can bring intelligent tissue platforms closer to clinical applications.
Image source: POSTECH.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2025 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotech - International biotech science
ScienceWeek - Biotechnology Science since 1997
Genetically modified yeast can create valuable materials from urine
Serotonin produced by gut bacteria provides hope for a novel IBS treatment